Prosecution Insights
Last updated: April 19, 2026
Application No. 17/999,244

MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCY

Non-Final OA §103
Filed
May 25, 2023
Examiner
PRAGANI, RAJAN
Art Unit
1614
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BEIERSDORF AG
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
3y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allow Rate
20 granted / 42 resolved
-12.4% vs TC avg
Strong +79% interview lift
Without
With
+78.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
45 currently pending
Career history
87
Total Applications
across all art units

Statute-Specific Performance

§101
7.3%
-32.7% vs TC avg
§103
52.1%
+12.1% vs TC avg
§102
6.5%
-33.5% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 42 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election of Group I (claims 18-32) in the reply filed on 12/01/2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Specifically, Applicant has not clarified whether the restriction is made with or without traverse. Claims 33-37 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Note this second restriction requirement occurred because the first restriction (filed 8/12/2025) led to Applicant rewriting and refining the claims (filed 8/29/2025), leading to a different numbering system, where the initial restriction numbering designation no longer applied. Applicant then requested a new written restriction requirement, as discussed by telephone, which was sent in agreement. Priority The present application is a National Stage entry of International application PCT/EP2021/061399 filed 04/30/2021, which claims the benefit of Foreign application DE10 2020 003 169.2 filed 05/27/2020. Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55, although it is noted that no English translation was provided. Status of the Application Receipt is acknowledged of Applicant’s claimed invention, filed 05/25/2023, in the matter of Application N° 17/999,244. Said documents have been entered on the record. The Examiner further acknowledges the following: Claims 18-37 are pending. Claims 33-37 are withdrawn from consideration as directed to non-elected inventions. Claims 18-32 are presented for examination and rejected as set forth below. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 18-24 and 26-32 are rejected under 35 U.S.C. 103 as being unpatentable over Von Der Fecht (US20150011654A1; cited on the IDS filed 1/13/2023), and in further view of Banowski (DE102008028822A1 – machine translation provided; cited on the IDS filed 1/13/2023) and Lorant (US20110020258A1; same patent family as WO 2009/080657 A2 which is directly discussed by Von Der Fecht). Applicant’s independent claim 18 is directed to a cosmetic water-in-oil emulsion (W/O emulsion) containing a) a first emulsifier from the group of the compounds diisostearoyl polyglyceryl-3 dimer dilinoleate and/or polyglyceryl-3 polyricinoleate b) a second emulsifier from the group of the compounds polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate and/or polyglyceryl-2 sesquioleate c) sunflower wax, wherein the preparation is free from a list of specific ingredients (with emphasis understood on “mineral oil-free” from the Application title. Further note that the “free from” negative limitations do not apply if the Art teaches the ingredients as optionally included; thus, it would be obvious to preclude these ingredients from a composition. The additional dependent claims further narrow the composition. Von Der Fecht teaches stable water-in-oil emulsions (W/O emulsion) for cosmetics intended for the skin [0009-0013] that produces desirable highly spreadable, flowable emulsions [0006, 0065]. Regarding claims 18-21 and 23: Von Der Fecht teaches a composition comprising diisostearoyl polyglyceryl-3 dimer dilinoleate in 0.1-3 wt% (reads on 18a and 19) and polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate in 0.1-2.5 wt% (reads on 18b and 19) (Von Der Fecht – claims 21 and 25). Note that Von Der Fecht does not require the instantly excluded ingredients of the “wherein” clause (i.e., mineral oil, waxes, copolymers, UV absorbers, preservatives, or PEG ethers/esters, etc.) (Von Der Fecht – claims 18, 21 and 25), whereby Von Der Fecht teaches a list of generally optional ingredients such as oils, waxes, etc. [0068]. With regard to the amounts of instant claim 23, Von Der Fecht teaches a water phase of 40-80 wt% and an oil phase of 0.1-40 wt% [0062], where natural oils are included for selection such as argan oil, etc. [0063]. For the instant ranges (compared to disclosures of the Art), a prima facie case of obviousness typically exists when the ranges of a claimed composition overlap the ranges disclosed in the prior art (see 2144.05(I)). See In re Peterson, 315 F.3d 1325, 1329 (Fed. Cir. 2003) (“A prima facie case of obviousness typically exists when the ranges of a claimed composition overlap the ranges disclosed in the prior art.”). Regarding claim 27: Von Der Fecht teaches cosmetic auxiliaries and further active ingredients, but does not require salts in the preparation (Von Der Fecht – claim 18, [0068]). Regarding claim 28: Von Der Fecht teaches incorporation of glycerol (reads on glycerin) in 7-15 wt% [0034]. Regarding claim 29: Von Der Fecht teaches incorporation of plant extracts [0068]. In summary, Von Der Fecht teaches the elements of the instant water-in-oil emulsion, wherein Von Der Fecht presents an advantage of producing a flowable emulsion composition [0065]. Von der Fecht also generally teaches the inclusion of cosmetic auxiliaries such as waxes and oils [0068], esters of fatty acids [0023], and stick [0018] and cream formulations [0057], for application to skin [0035, 0041, 0057], as obvious for application to water-in-oil emulsions (title, abstract). However, Von Der Fecht does not teach the sunflower wax and amount (instant claims 18, 22, and 30), C14-C62 esters (instant claim 24), beeswax (instant claim 26), a lipstick formulation (instant claim 31), and a lip cream formulation (instant claim 32). Banowski (who is referenced by the disclosure of Von Der Fecht [0018] for information on emulsifiers and oils within cosmetic emulsion formulations, which applies to stick cosmetics [0018]), teaches application of stick [0111] and cream [0002, 0037, 0351] formulations to the lips [0111]. Additionally, Banowski teaches sunflower wax [0047] and beeswax [0047], where the wax component is 2.5-20 wt% [0056]. Note that "[A] prior art reference that discloses a range encompassing a somewhat narrower claimed range is sufficient to establish a prima facie case of obviousness." In re Peterson, 315 F.3d 1325, 1330, 65 USPQ2d 1379, 1382-83 (Fed. Cir. 2003) (see 2144.05(I)). Finally, Banowski generally teaches long-chain (including C16-C24) esters in cosmetics [0048]. Lorant (who is referenced by the disclosure of Von Der Fecht [0022] by way of WO 2009/080657 A2 on W/O emulsions [0022]), also teaches that W/O emulsion compositions can be formulated for application to the lips (abstract). It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Von Der Fecht with the waxes, esters, and amounts of Banowski (specifically, the sunflower wax, esters, and beeswax) because Von Der Fecht cites Banowski for information on emulsifiers and oils that applies to stick cosmetics [0018], and Von Der Fecht also generally teaches the inclusion of cosmetic auxiliaries such as waxes and oils [0068]. The selection of a known material based on its suitability for its intended use supported a prima facie obviousness determination in Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945). Furthermore, emulsified waxes impart a soft, light skin feel [0003], as taught by Banowski. It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Von Der Fecht to incorporate lipstick and lip cream formulations because Von Der Fecht generally teaches stick [0018] and cream formulations [0057], for application to skin [0035, 0041, 0057], as obvious, and references cited within Von Der Fecht (i.e., Banowski and Lorant) clarify that application of sticks and creams to the lips are obvious applications of the W/O emulsion compositions taught by Von Der Fecht. Regarding the obviousness of the combined amounts and ingredients of claim 30: Von Der Fecht teaches a composition comprising diisostearoyl polyglyceryl-3 dimer dilinoleate in 0.1-3 wt% (reads on “(a)”) and polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate in 0.1-2.5 wt% (reads on “(b)”) (Von Der Fecht – claims 21 and 25). Banowski (referenced by Von Der Fecht) teaches sunflower wax [0047] (reads on “(c)”), where the wax component is 2.5-20 wt% [0056]. Because the amounts encompass the instant amounts, the instant amounts are obvious: Note that "[A] prior art reference that discloses a range encompassing a somewhat narrower claimed range is sufficient to establish a prima facie case of obviousness." In re Peterson, 315 F.3d 1325, 1330, 65 USPQ2d 1379, 1382-83 (Fed. Cir. 2003) (see 2144.05(I)). Claims 18-32 are rejected under 35 U.S.C. 103 as being unpatentable over Von Der Fecht (US20150011654A1), Banowski (DE102008028822A1), and Lorant (US20110020258A1), as applied to claims 18-24 and 26-32 above, and in further view of Phoenix Chemical (Advances in Green Chemistry, 2019), as evidenced by Cosmetic Ingredient Review (2013). As described above, Von Der Fecht, Banowski, and Lorant teach almost the entirety of the instant composition. However, they do not teach specifically behenyl behenate (instant claim 25). Phoenix Chemical teaches behenyl behenate (i.e., Pelemol BB) among a number of other related ingredients useful for lipsticks to help stabilize emulsions (pg 3). As evidenced by Cosmetic Ingredient Review, behenyl behenate is a C21 alkyl ester (pg 13, #36). It would have been prima facie obvious for one of ordinary skill in the art before the effective filing date of the claimed invention to modify the teachings of Von Der Fecht and Banowski with behenyl behenate (i.e., a C21 alkyl ester) taught by Phoenix Chemical because Von Der Fecht generally teaches the inclusion of cosmetic auxiliaries and further active ingredients such as waxes and oils [0068] and Banowski generally teaches long-chain (including C16-C24) esters in cosmetics [0048]. The selection of a known material based on its suitability for its intended use supported a prima facie obviousness determination in Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945). Furthermore, a PHOSITA would be motivated to incorporate behenyl behenate because it helps stabilize emulsions (pg 3) as taught by Phoenix Chemical, in which Von Der Fecht teaches W/O emulsions (abstract) for stick cosmetic formulations [0018]. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to RAJAN PRAGANI whose telephone number is (703)756-5319. The examiner can normally be reached 7a-5p EST (M-Th). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ali Soroush can be reached on 571-272-9925. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /R.P./Examiner, Art Unit 1614 1/22/2026 /SEAN M BASQUILL/Primary Examiner, Art Unit 1614
Read full office action

Prosecution Timeline

May 25, 2023
Application Filed
Aug 12, 2025
Response after Non-Final Action
Aug 29, 2025
Response after Non-Final Action
Jan 29, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589070
LOW-DOSAGE ORODISPERSIBLE OPIOID TABLET AND METHOD FOR PREPARING SAME
2y 5m to grant Granted Mar 31, 2026
Patent 12589076
GELATIN CAPSULES WITH GROUND CALCIUM CARBONATE
2y 5m to grant Granted Mar 31, 2026
Patent 12582590
A TRANSPARENT LIQUID COMPOSITION AND COSMETIC CONTAINING SAID COMPOSITION
2y 5m to grant Granted Mar 24, 2026
Patent 12569426
TOPICAL SKIN PREPARATION COMPOSITION
2y 5m to grant Granted Mar 10, 2026
Patent 12558313
GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND PREVENTION OF PULMONARY DISEASES
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
99%
With Interview (+78.6%)
3y 6m
Median Time to Grant
Low
PTA Risk
Based on 42 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month